PreciPoint is a digital microscope and pathology platform dedicated to the development of digital microscopes and pathology services for use in cancer surgery, specializing in the development, production and marketing of digital solutions and photonic systems. PreciPoint is also working to transform the future of pathology laboratories by developing products that combine optics with compact and high-precision hardware designs, as well as ease-of-use and powerful software. PreciPoint has recently completed a series A financing of 10 million euros. Investors include bm-t beteiligungsmanagement thüringen gmbh (bm|t) and a new family office.
This article is reproduced from: https://www.itjuzi.com/investevent/13463448
This site is for inclusion only, and the copyright belongs to the original author.